EurekaMag.com logo
+ Site Statistics
References:
53,214,146
Abstracts:
29,074,682
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on Google+Follow on Google+
Follow on LinkedInFollow on LinkedIn

+ Translate

Disposition of pulse dose methyl prednisolone in adult and pediatric patients with the nephrotic syndrome



Disposition of pulse dose methyl prednisolone in adult and pediatric patients with the nephrotic syndrome



European Journal of Clinical Pharmacology 23(5): 429-434



The disposition of a large pulse-dose of methylprednisolone was examined in pediatric and adult patients with the nephrotic syndrome. Plasma concentrations and urinary excretion rates were measured by high-performance liquid chromatography. Most of the dose was metabolized, as indicated by urinary recovery of < 10% of the dose. There was only slight age-dependence of the plasma clearance and volume of distribution of the steroid, although the t1/2 [half-life] and mean transit time were shorter in younger patients. The pharmacokinetic parameters of the large doses (12-20 mg/kg) were similar to low dose (0.5-1 mg/kg) data from asthmatic patients. The limited variability of the pharmacokinetics of methylprednisolone suggests that tissue sensitivity may be a more important indicator of drug dosage needs in nephrotic syndrome.

(PDF 0-2 workdays service: $29.90)

Accession: 005170955

Download citation: RISBibTeXText

PMID: 7151847



Related references

Pulse methyl prednisolone in frequently relapsing nephrotic syndrome. Clinical Research 27(1): 133A, 1979

Pulse methyl prednisolone therapy of nephrotic syndrome with focal glomerulo sclerosis. Pediatric Research 18(4 PART 2): 368A, 1984

In vitro sensitivity to methyl-prednisolone is associated with clinical response in pediatric idiopathic nephrotic syndrome. Clinical Pharmacology and Therapeutics 100(3): 268-274, 2016

Study on high-dose intravenous methylprednisolone pulse therapy in adult patients with minimal change nephrotic syndrome. Journal of the American Society of Nephrology 11(Program and Abstract Issue): 87A, September, 2000

Complete remission induced by tacrolimus and low-dose prednisolone in adult minimal change nephrotic syndrome: A pilot study. Kidney Research and Clinical Practice 31(2): 112-117, 2012

Effect of high dose intra venous methyl prednisolone therapy in frequently relapsing and steroid resistant nephrotic syndrome in children. Kidney International 8(6): 415, 1975

Increased prevalence of elevated lipoprotein in pediatric patients with idiopathic nephrotic syndrome compared to adult nephrotic patients. Journal of the American Society of Nephrology 5(3): 326, 1994

Favorable outcome of low-dose cyclosporine after pulse methylpredonisolone in Japanese adult nephrotic syndrome. Journal of the American Society of Nephrology 13(Program and Abstracts Issue): 668A, September, 2002

Effect on nephrotic syndrome on absorption and disposition of prednisolone in children. International Journal of Pediatric Nephrology 3(3): 159-166, 1982

Simultaneous determination of prednisolone, prednisone, cortisol, and cortisone in plasma by GC-MS: estimating unbound prednisolone concentration in patients with nephrotic syndrome during oral prednisolone therapy. Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences 870(2): 164-169, 2008

Favorable outcome of low-dose cyclosporine afteir pulse methylprednisolone in Japanese adult minimal-change nephrotic syndrome. Internal Medicine (Tokyo) 43(8): 668-673, August, 2004

Combined cyclosporine and prednisolone therapy in adult patients with the first relapse of minimal-change nephrotic syndrome. Nephrology, Dialysis, Transplantation 25(1): 124-129, 2010

Troleandomycin inhibition of methyl prednisolone elimination in pediatric and adult asthmatic patients. Clinical Pharmacology & Therapeutics 29(2): 285, 1981

Pharmacokinetic Study of Oral Prednisolone in Children with Nephrotic Syndrome Serum Concentration of Prednisolone in both Nephrotic and Remission Stage. Pediatrics International 24(3): 396-396, 1980

Low dose prednisolone in nephrotic syndrome. Archives of Disease in Childhood 64(4): 610-611, 1989